Smartphone-Based Detection of Antithrombin in Blood Plasma

Summary: 

Antithrombin (AT) is a protein that plays a critical role in regulating the coagulation cascade, a series of reactions involving clotting factors to stop bleeding. AT deficiencies can significantly increase an individual’s risk of dangerous blood clots. The currently available methods for detecting AT levels are not portable, rapid, or simple enough to be used in urgent and clinical settings. The overarching aim of this study was to explore a rapid, easy-to-use, low-cost, and portable test that can be translated into real-world clinical and field applications. The researchers created a paper-based microfluidic system that uses blood capillary flow behavior as an indirect indicator of AT activity. The results showed that the system could reliably detect and quantify differences in AT levels. Samples with lower AT concentrations produced distinctly different flow behaviors compared to those with higher levels, demonstrating a clear relationship between AT activity and flow dynamics. Importantly, the method offers a significant improvement in speed, producing results in just over one second using smartphone-based video analysis. This makes it much faster than conventional assays while still maintaining reliable measurement capability. Overall, this work presents a novel and promising approach for rapid AT testing using a low-cost, portable platform based on capillary flow observation in paper chips. 

What is antithrombin? 

Antithrombin (AT) plays a crucial role in regulating the blood coagulation cascade by inhibiting enzymes such as thrombin and factor Xa. AT deficiency can be hereditary or acquired over time, with hereditary AT deficiency being further classified into two groups: 1) Type I, characterized by a reduced AT amount, or 2) Type II, characterized by reduced functional activity of AT. Many factors may cause AT deficiency, including advanced liver disease, sepsis, major trauma and surgery, and certain medications. When AT levels are reduced or dysfunctional, the body becomes more prone to forming abnormal clots, increasing the risk of conditions like deep vein thrombosis and pulmonary embolism. These are conditions where blood clots can form in areas like the legs, then travel to other regions of the body and block vital circulation, causing cell death. Despite its clinical importance, the testing for AT deficiency is typically performed in specialized laboratories using complex equipment, which can delay diagnosis and limit accessibility. Given these circumstances, there is a growing need for rapid, simple, and widely accessible diagnostic tools that can facilitate earlier detection and monitoring. Advances in mobile technology and microfluidics have made it possible to design assays that are both portable and cost-effective, motivating the development of the smartphone-based method explored in this study. 

What were the methods of data collection and analysis? 

This study used a controlled laboratory method to measure AT levels by combining paper-based microfluidics with smartphone imaging. The researchers used both simple buffer solutions and human blood plasma to represent real biological conditions. Small amounts of each sample were placed onto paper microfluidic chips, where the liquid moved through narrow channels by capillary action. As the fluid traveled along the paper, a smartphone camera recorded the motion in real time. Capillary flow velocities were collected over the following time frames: 0–25, 0–30, 0–35, and 0–40, and the average flow velocities with six different AT concentrations were collected. Each data set was analyzed using the statistical method Analysis of Variance (ANOVA) to calculate p-values. The main data collected was the speed of the advancing liquid front, which changes depending on the amount of AT present in the sample. 

To further analyze the data, the recorded videos were processed to measure the flow velocity of the liquid. This was done by tracking how far the liquid front moved over time and calculating its rate of motion along the paper strip. These flow speeds were then compared to the known AT concentrations in each sample. By plotting flow speed against concentration, the researchers found a consistent, roughly linear relationship. This means that the speed of the fluid can be used as an indirect but reliable measure of AT levels. 

To confirm the method’s reliability, the researchers compared results from the simple buffer samples with those from human plasma samples. This step was important because plasma contains many additional proteins and components that could affect fluid flow. By evaluating how closely the results matched between these different sample types, the researchers assessed the assay’s accuracy, sensitivity, and overall reliability. 

What were the results of this study? 

The study found that the assay could reliably distinguish between different AT concentrations based on changes in capillary flow behavior. Samples with lower AT levels produced noticeably different flow patterns compared to those with normal levels, demonstrating a clear and measurable correlation between AT activity and fluid movement. The flow signal followed a logarithmic relationship with concentration, meaning that increases in AT produced predictable changes in flow speed, allowing the researchers to create a calibration curve for estimating unknown samples. Because the relationship is consistent, the system can be used not just to detect AT, but to measure how much is present. When the curve was plotted against the logarithm of AT concentration, a good linear relationship was observed, with an R² value of 0.988. R² values range from 0 to 1, with a value closer to 1 indicating that the model is a good fit and predictions are more reliable. 

In addition to accuracy, the method offered several practical advantages. The assay required only a small volume of plasma, produced results relatively quickly, and did not rely on bulky or expensive laboratory equipment. This differs from the more traditional methods for detecting AT levels, which can take up to a few hours to process. The use of a smartphone for data capture and analysis further enhances accessibility, as it leverages widely available technology. These results indicate that the method is not only scientifically valid but also highly practical for real-world applications, particularly in settings where traditional laboratory testing is not feasible. 

What is the importance of early detection of antithrombin deficiency? 

Being able to quickly detect AT deficiency is very important for patient care. Whether inherited or acquired, low AT levels increase the risk of dangerous blood clots, often in individuals at a younger age. AT helps blood continue to flow without unusual clotting, so lower levels of AT mean that blood is more prone to clot and form an embolism or thrombosis. Early detection allows healthcare providers to take preventive steps, such as prescribing anticoagulants, recommending lifestyle changes, or increasing monitoring. These actions can help reduce serious complications like pulmonary embolism. 

A rapid, portable AT test would allow doctors to diagnose deficiencies directly at the point of care and begin treatment only when necessary. This can improve patient safety while also reducing unnecessary costs and use of medical resources. It is especially useful in high-risk situations, such as cardiopulmonary bypass procedures, where precise control of blood clotting is critical. Early diagnosis also helps with family screening, since AT deficiency is often inherited, allowing relatives to be tested and treated if needed. By removing the need for complex laboratory testing, this portable method makes AT detection faster and more accessible. Overall, it has the potential to improve patient outcomes, support better clinical decisions, and reduce the impact of clotting disorders.